Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
International Journal of Pharmaceutics|March 4, 2006
In vitro investigation of lipid implants as a controlled release system for interleukin-18S Koennings, E Garcion, N Faisant, et al.International Journal of Pharmaceutics|January 3, 2006
Development of new polymer-based particulate systems for anti-glioma vaccinationA Sapin, E Garcion, A Clavreul, et al.International Journal of Pharmaceutics|June 18, 2013
Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cellsM Weyland, A Griveau, J Bejaud, et al.International Journal of Pharmaceutics|March 7, 2006
Development and characterization of interleukin-18-loaded biodegradable microspheresF Lagarce, E Garcion, N Faisant, et al.Brain Research|June 10, 1996
Early events of the inflammatory reaction induced in rat brain by lipopolysaccharide intracerebral injection: relative contribution of peripheral monocytes and activated microgliaC N Montero-Menei, L Sindji, E Garcion, et al.International Journal of Pharmaceutics|June 21, 2011
Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133E Bourseau-Guilmain, J Béjaud, A Griveau, et al.Acta Biomaterialia|September 12, 2012
Smart nanocarriers for pH-triggered targeting and release of hydrophobic drugsS Cajot, K Van Butsele, A Paillard, et al.European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|January 29, 2013
Perfluorocarbon-loaded lipid nanocapsules as oxygen sensors for tumor tissue pO₂ assessmentL Lemaire, G Bastiat, F Franconi, et al.Neuroscience Letters|October 4, 1996
1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brainE Garcion, X D Thanh, F Bled, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 9, 2010
Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1M Weyland, F Manero, A Paillard, et al.Pageof 3